These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 9527904

  • 1. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Idezuka J, Tsuji S.
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [Abstract] [Full Text] [Related]

  • 2. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K, Tanaka M, Onodera O, Tsuji S.
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [Abstract] [Full Text] [Related]

  • 3. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
    Tanaka M, Tanaka K.
    Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
    [Abstract] [Full Text] [Related]

  • 4. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K, Tanaka M, Onodera O, Igarashi S, Tsuji S.
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S.
    J Neurol Sci; 1998 Nov 26; 161(1):88-90. PubMed ID: 9879687
    [Abstract] [Full Text] [Related]

  • 6. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb 26; 97(1):101-5. PubMed ID: 7788964
    [Abstract] [Full Text] [Related]

  • 7. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
    Holzmann P, Holy D, Stillhard G, Janda M, Möbr P.
    Schweiz Med Wochenschr; 1998 Jun 06; 128(23):906-8. PubMed ID: 9658519
    [Abstract] [Full Text] [Related]

  • 8. [A study on pathomechanisms of paraneoplastic neurological syndrome].
    Tanaka K.
    Rinsho Shinkeigaku; 2001 Dec 06; 41(12):1150-2. PubMed ID: 12235823
    [Abstract] [Full Text] [Related]

  • 9. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M, Tanaka K, Onodera O, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb 06; 97(1):95-100. PubMed ID: 7788981
    [Abstract] [Full Text] [Related]

  • 10. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
    Tanaka M, Tanaka K, Tsuji S.
    Neurodegeneration; 1994 Dec 06; 3(4):341-2. PubMed ID: 7842305
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Tokiguchi S, Shinozawa K, Tsuji S.
    J Neurol Sci; 1999 Sep 15; 168(1):28-31. PubMed ID: 10500270
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration.
    Tanaka M, Tanaka K, Tsuji S, Kawata A, Kojima S, Kurokawa T, Kira J, Takiguchi M.
    J Neurol Sci; 2001 Jul 15; 188(1-2):61-5. PubMed ID: 11489286
    [Abstract] [Full Text] [Related]

  • 13. Tumor-specific killer cells in paraneoplastic cerebellar degeneration.
    Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB.
    Nat Med; 1998 Nov 15; 4(11):1321-4. PubMed ID: 9809559
    [Abstract] [Full Text] [Related]

  • 14. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Nakajima T, Yamazaki M, Miyatake T, Tsuji S.
    J Neurol Neurosurg Psychiatry; 1995 Feb 15; 58(2):256-7. PubMed ID: 7876871
    [No Abstract] [Full Text] [Related]

  • 15. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
    Sutton IJ, Steele J, Savage CO, Winer JB, Young LS.
    J Neuroimmunol; 2004 May 15; 150(1-2):98-106. PubMed ID: 15081253
    [Abstract] [Full Text] [Related]

  • 16. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.
    Storstein A, Monstad SE, Honnorat J, Vedeler CA.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):150-4. PubMed ID: 15342206
    [Abstract] [Full Text] [Related]

  • 17. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
    Cohen AB, Zupa-Fernandez A, Dalmau J, Galetta SL.
    J Neurol Sci; 2004 Oct 15; 225(1-2):153-5. PubMed ID: 15465100
    [Abstract] [Full Text] [Related]

  • 18. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N, Kes P, Basić-Kes V, Brunetta B.
    Acta Med Croatica; 2004 Oct 15; 58(1):63-6. PubMed ID: 15125396
    [Abstract] [Full Text] [Related]

  • 19. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K, Saltzman JR, Carr-Locke DL.
    MedGenMed; 2003 Aug 05; 5(3):18. PubMed ID: 14600654
    [Abstract] [Full Text] [Related]

  • 20. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W, Drlicek M, Liszka U.
    Nervenarzt; 1991 Oct 05; 62(10):609-14. PubMed ID: 1749452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.